news & announcements archive

 Jan 16, 2019

"Can Topical Drugs Help Prevent Breast Cancer? Originally published by the National Cancer Institute."

A gel form of tamoxifen, which is applied to the breasts, is being tested to prevent breast cancer. Credit: National Cancer Institute

 Jan 16, 2019

"Vitamin D Supplements Don’t Reduce Cancer Incidence, Trial Shows was originally published by the National Cancer Institute"

Findings from a large clinical trial show that taking vitamin D supplements does not lower cancer risk. Credit: National Cancer Institute

 Jan 16, 2019

"The HPV Vaccine: Increasing the Use of an Important Cancer Prevention Tool was originally published by the National Cancer Institute"

A new President’s Cancer Panel report concludes that, despite important progress, more work is needed to increase HPV vaccine uptake.

 Jan 16, 2019

"For Early-Stage Lung Cancer, Study Identifies Potential New Biomarker, Treatment Target was originally published by the National Cancer Institute"

The potential new biomarker is a protein called SGLT2, which is used to transport glucose into some cells. The study authors also found that, in mice, they could use PET scans to detect early-stage lung lesions that use SGLT2 to transport glucose.

 Aug 18, 2015

NCI-MATCH Precision Medicine Cancer Trial Opens

NCI-MATCH, the largest, most scientifically rigorous precision medicine trial in cancer to date, is now opening at cancer centers and community hospitals across the country...

 Aug 14, 2015

Why clinical trial recruitment is so hard, and one solution: Patient education

Clinical trials are the lifeblood of the life sciences industry – yet less than 5 percent of adult cancer patients will pursue experimental therapies. The biggest reason for this? Fear...

 Aug 13, 2015

National Cancer Institute NCI-Match Clinical Trials Are Now Open

National Cancer Institute-Molecular Analysis for Therapy Choice, known as NCI-MATCH or study EAY131, is a phase II precision medicine trial that seeks to determine whether matching certain drugs or drug combinations in adults whose tumors have specific gene abnormalities will effectively treat their cancer, regardless of their cancer type.

 Aug 11, 2015

Minority Clinical Trial Participation Reveals Historical, Social Issues

Minority populations in the United States are at a greater risk of developing certain diseases like cancer, hypertension and other chronic illnesses. Yet these populations are commonly underrepresented in clinical trials...